PT - JOURNAL ARTICLE AU - Bradley, Heather AU - Fahimi, Mansour AU - Sanchez, Travis AU - Lopman, Ben AU - Frankel, Martin AU - Kelley, Colleen F. AU - Rothenberg, Richard AU - Siegler, Aaron J AU - Sullivan, Patrick S TI - Early Release Estimates for SARS-CoV-2 Prevalence and Antibody Response Interim Weighting for Probability-Based Sample Surveys AID - 10.1101/2020.09.15.20195099 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.15.20195099 4099 - http://medrxiv.org/content/early/2020/10/08/2020.09.15.20195099.short 4100 - http://medrxiv.org/content/early/2020/10/08/2020.09.15.20195099.full AB - The authors have withdrawn this manuscript because analytic strategies for this project have changed. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNIH NIAID 3R01AI143875-02S1, Woodruff FoundationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Emory University Institutional Review Board (protocol 00000695)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes